Clinical Trials in Pittsburgh

Showing 7161-7180 of 21,047 trials

EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer

NCT05978960

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements in conjunction with a nutrition regimen focused on food quality under close supervision on women who have been treated for breast cancer.

Breast Cancer

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)44 participantsStarted May 2023

Pittsburgh, Pennsylvania, United States

COMPLETEDEARLY Phase 1< 1 mile

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

NCT02913430

To assess longitudinal changes in allele frequency of ESR1 mutation in plasma in patients treated with Fulvestrant plus palbociclib compared to tamoxifen plus palbociclib

Metastatic Breast Cancer

Shannon Puhalla7 participantsStarted Apr 2018

Pittsburgh, Pennsylvania, United States

COMPLETED56 miles

Palbociclib in Real World Practice

NCT03280303

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.

Advanced Breast CancerMetastatic Breast Cancer

Pfizer1,285 participantsStarted Jan 2017

Alabaster, Alabama, United States • Bessemer, Alabama, United States • Birmingham, Alabama, United States +302 more locations

EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

Palbociclib in Real World Practice

Find Trials by Condition in Pittsburgh

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

Prostate Imaging Using MRI +/- Contrast Enhancement

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

TelemEdiciNe-bAsed Cognitive TherapY for Migraines

An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry